EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Updates and validation of the Compi RNA-seq pipeline with a case study in Alzheimer’s disease

Rosalinda Di Gerlando, Stella Gagliardi, Hugo López-Fernández

Journal of Integrative Bioinformatics · 17.06.2026

DOI: 10.1515/jib-2025-0064 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Integrative Bioinformatics, online erschienen am 17.06.2026. Verfasst von Rosalinda Di Gerlando und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology and Biotechnology "L. Spallanzani", University of Pavia, 27100 Pavia, Italy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

RNA-seq data analysis is a multi-step process that typically includes demultiplexing, alignment to the reference genome, read counting and genome annotation, ultimately leading to differential expression analysis (DEA). Several pipelines are currently available to support these steps and produce outputs adapted to specific experimental needs. Such pipelines must also ensure reproducibility, offer user-friendly implementation, support the analysis of complex genomes, allow batch correction, and remain sufficiently flexible to enable customization. Here , we present version 2.2 of a fully customizable command-line RNA-seq pipeline, developed within the Compi framework through the conversion and extension of the previously established DEWE graphical user interface tool. This updated version includes tasks for FASTQ quality control, two alternative read-counting strategies, and recently developed tools for DEA and pathway analysis, such as DElite and RCPA. Furthermore, we apply the pipeline to an exploratory RNA-seq study comparing transcriptomic profiles of Alzheimer’s disease (AD) patients with healthy controls (HC) to identify putative disease molecular signatures and assess the pathways affected by the disease.

Schlagwörter

Stichwörter der Autor:innen

Alzheimer’s diseaseRNA-seqbioinformaticsdifferential expression analysispipelines

Autor:innen und Institutionen

  • Department of Biology and Biotechnology "L. Spallanzani", University of Pavia, 27100 Pavia, Italy.
  • Molecular Biology and Transcriptomics Unit, IRCCS Mondino Foundation, 27100 Pavia, Italy.
  • SING Research Group, Galicia Sur Health Research Institute (IIS Galicia Sur), SERGAS-UVIGO, 36213 Vigo, Spain.

Zitieren

APA

Di Gerlando, R., Gagliardi, S., & López-Fernández, H. (2026). Updates and validation of the Compi RNA-seq pipeline with a case study in Alzheimer’s disease. Journal of Integrative Bioinformatics. https://doi.org/10.1515/jib-2025-0064

Vancouver

Di Gerlando R, Gagliardi S, López-Fernández H. Updates and validation of the Compi RNA-seq pipeline with a case study in Alzheimer’s disease. Journal of Integrative Bioinformatics. 2026. doi:10.1515/jib-2025-0064

BibTeX
@article{DiGerlando2026,
  author = {Di Gerlando, Rosalinda and Gagliardi, Stella and López-Fernández, Hugo},
  title = {Updates and validation of the Compi RNA-seq pipeline with a case study in Alzheimer’s disease},
  journal = {Journal of Integrative Bioinformatics},
  year = {2026},
  doi = {10.1515/jib-2025-0064}
}
Kostenlos starten →